Analysis of Evidence Map of Traditional Chinese Medicine lntervention in Chronic Obstructive Pulmonary Disease
- VernacularTitle:中医药干预慢性阻塞性肺疾病的证据图谱分析
- Author:
Xingyuan WANG
1
;
Ningzi ZANG
;
Lijian PANG
;
Xiaodong LYU
Author Information
- Publication Type:Journal Article
- Keywords: Chinese medicine; Chronic obstructive pulmonary disease; Evidence map; AMSTAR 2 scale
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(3):842-855
- CountryChina
- Language:Chinese
- Abstract: Objective To apply the evidence mapping system,the evidence of traditional Chinese medicine related research on chronic obstructive pulmonary disease intervention was identified,described and evaluated.Methods CNKI,Wanfang,VIP,SinoMed,PubMed,Web of Science,Cochrane Library and other databases were searched before November 2023 to obtain systematic review/meta-analysis/network meta-analysis.The AMSTAR 2 scale was used to evaluate the quality of the included studies.Results A total of 111 systematic reviews/Meta-analysis/network Meta-analysis were included.In the observation group,most of them were treated with traditional Chinese medicine decoction,and the treatment methods were mostly warming,eliminating,clearing and so on.Traditional Chinese medicine treatment of chronic obstructive pulmonary disease could increase lung function and 6-minute walking distance(6WMD),improve efficiency and arterial oxygen partial pressure(PaO2),relieve clinical symptoms and improve the quality of life of patients.According to the evaluation results of AMSTAR 2 scale,the overall methodological quality of systematic review/Meta-analysis was not high,and there was a lack of sufficient evidence to support the efficacy of TCM treatment.Conclusion Traditional Chinese medicine has a certain effect on the treatment of chronic obstructive pulmonary disease,but the quality of evidence included in the literature needs to be improved.In the future,high-quality research should be carried out to provide evidence-based evidence.
